Skip to content
Search

Latest Stories

RPS guide to help pharmacy teams make informed decisions during COVID-19 pandemic

The Royal Pharmaceutical Society has published a guide to help pharmacy teams make informed decisions while dealing with difficult situations linked to COVID-19.

The guidance – developed by a diverse group of professionals, including regulators, academics and pharmacy law experts – is meant for pharmacy professionals in all settings, who are involved in strategic planning or front-line roles.


According to the RPS, it "provides helpful reminders about the process of reasoned decision making, the national pandemic ethical framework and some considerations about specific areas of importance to pharmacists and pharmacy technicians.

"The varied experiences of the guidance contributors brings together a wide range of up to the moment professional issues that many may or will be facing."

The pharmacy body reassures pharmacists and pharmacy technicians that "should decisions be called into question at a later date, they will be judged according to the circumstances at the time of the decision, not with the benefit of hindsight."

RPS President Sandra Gidley said: “This guidance will help pharmacy professionals to take responsibility for making difficult but informed decisions. It provides reassurance that those decisions are the right thing to do given the pandemic situation.”

Chair of the guidance working group, Dr Matthew Boyd from the University of Nottingham and Pharmacy Law and Ethics Association, said: “The willingness of so many senior members of our professional family to volunteer to contribute to this document, and at speed, summarises the drive and compassion amongst our number for high standards of patient care.

“The guidance has had comment from all sectors of the pharmacy team to provide maximum coverage. Appropriately applied, the frameworks should support all required decisions during the pandemic.”

The RPS guidance has the support of General Pharmaceutical Council, the Pharmaceutical Society NI and the Association of Pharmacy Technicians UK.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less